nodes	percent_of_prediction	percent_of_DWPC	metapath
Zoledronate—ABCC1—breast cancer	0.366	1	CbGaD
Zoledronate—ABCC1—Idarubicin—breast cancer	0.0989	0.296	CbGbCtD
Zoledronate—ABCC1—Mitoxantrone—breast cancer	0.0425	0.127	CbGbCtD
Zoledronate—ABCC1—Epirubicin—breast cancer	0.0344	0.103	CbGbCtD
Zoledronate—ABCC1—Paclitaxel—breast cancer	0.0339	0.102	CbGbCtD
Zoledronate—ABCC1—Irinotecan—breast cancer	0.0335	0.1	CbGbCtD
Zoledronate—ABCC1—Vinblastine—breast cancer	0.0298	0.0892	CbGbCtD
Zoledronate—ABCC1—Docetaxel—breast cancer	0.0245	0.0736	CbGbCtD
Zoledronate—ABCC1—Doxorubicin—breast cancer	0.0183	0.0548	CbGbCtD
Zoledronate—ABCC1—Methotrexate—breast cancer	0.0177	0.0531	CbGbCtD
Zoledronate—GGPS1—nipple—breast cancer	0.0036	0.0803	CbGeAlD
Zoledronate—GGPS1—endometrium—breast cancer	0.00217	0.0485	CbGeAlD
Zoledronate—GGPS1—uterus—breast cancer	0.002	0.0447	CbGeAlD
Zoledronate—GGPS1—pituitary gland—breast cancer	0.00196	0.0439	CbGeAlD
Zoledronate—GGPS1—adipose tissue—breast cancer	0.00196	0.0437	CbGeAlD
Zoledronate—GGPS1—female reproductive system—breast cancer	0.0018	0.0402	CbGeAlD
Zoledronate—GGPS1—adrenal gland—breast cancer	0.00176	0.0392	CbGeAlD
Zoledronate—GGPS1—bone marrow—breast cancer	0.0017	0.0379	CbGeAlD
Zoledronate—FDPS—nipple—breast cancer	0.00166	0.037	CbGeAlD
Zoledronate—GGPS1—female gonad—breast cancer	0.00164	0.0365	CbGeAlD
Zoledronate—GGPS1—endocrine gland—breast cancer	0.00152	0.034	CbGeAlD
Zoledronate—FDPS—skin of body—breast cancer	0.00106	0.0237	CbGeAlD
Zoledronate—GGPS1—lymph node—breast cancer	0.00105	0.0235	CbGeAlD
Zoledronate—CA14—adrenal gland—breast cancer	0.00105	0.0234	CbGeAlD
Zoledronate—FDPS—endometrium—breast cancer	0.001	0.0223	CbGeAlD
Zoledronate—ABCC1—nipple—breast cancer	0.000963	0.0215	CbGeAlD
Zoledronate—FDPS—uterus—breast cancer	0.000922	0.0206	CbGeAlD
Zoledronate—FDPS—pituitary gland—breast cancer	0.000906	0.0202	CbGeAlD
Zoledronate—FDPS—adipose tissue—breast cancer	0.000902	0.0201	CbGeAlD
Zoledronate—CA2—nipple—breast cancer	0.000861	0.0192	CbGeAlD
Zoledronate—CA12—female reproductive system—breast cancer	0.000838	0.0187	CbGeAlD
Zoledronate—FDPS—female reproductive system—breast cancer	0.000829	0.0185	CbGeAlD
Zoledronate—FDPS—adrenal gland—breast cancer	0.000809	0.0181	CbGeAlD
Zoledronate—FDPS—bone marrow—breast cancer	0.000783	0.0175	CbGeAlD
Zoledronate—FDPS—female gonad—breast cancer	0.000754	0.0168	CbGeAlD
Zoledronate—CA2—embryo—breast cancer	0.00071	0.0159	CbGeAlD
Zoledronate—CA12—endocrine gland—breast cancer	0.000709	0.0158	CbGeAlD
Zoledronate—FDPS—endocrine gland—breast cancer	0.000702	0.0157	CbGeAlD
Zoledronate—ABCC1—endometrium—breast cancer	0.000581	0.013	CbGeAlD
Zoledronate—CA2—epithelium—breast cancer	0.000579	0.0129	CbGeAlD
Zoledronate—CA2—skin of body—breast cancer	0.000551	0.0123	CbGeAlD
Zoledronate—ABCC1—uterus—breast cancer	0.000536	0.012	CbGeAlD
Zoledronate—ABCC1—pituitary gland—breast cancer	0.000526	0.0117	CbGeAlD
Zoledronate—ABCC1—adipose tissue—breast cancer	0.000524	0.0117	CbGeAlD
Zoledronate—FDPS—lymph node—breast cancer	0.000485	0.0108	CbGeAlD
Zoledronate—CA2—pituitary gland—breast cancer	0.00047	0.0105	CbGeAlD
Zoledronate—ABCC1—adrenal gland—breast cancer	0.00047	0.0105	CbGeAlD
Zoledronate—CA2—adipose tissue—breast cancer	0.000468	0.0105	CbGeAlD
Zoledronate—ABCC1—female gonad—breast cancer	0.000438	0.00978	CbGeAlD
Zoledronate—CA2—female reproductive system—breast cancer	0.00043	0.00961	CbGeAlD
Zoledronate—CA2—adrenal gland—breast cancer	0.00042	0.00938	CbGeAlD
Zoledronate—CA2—bone marrow—breast cancer	0.000406	0.00907	CbGeAlD
Zoledronate—CA2—female gonad—breast cancer	0.000392	0.00875	CbGeAlD
Zoledronate—CA2—endocrine gland—breast cancer	0.000364	0.00813	CbGeAlD
Zoledronate—ABCC1—lymph node—breast cancer	0.000282	0.00629	CbGeAlD
Zoledronate—CA2—lymph node—breast cancer	0.000252	0.00562	CbGeAlD
Zoledronate—Risedronate—PTGS2—breast cancer	0.000202	0.529	CrCbGaD
Zoledronate—Clodronate—PTGS2—breast cancer	0.00018	0.471	CrCbGaD
Zoledronate—Headache—Fluorouracil—breast cancer	2.66e-05	0.000137	CcSEcCtD
Zoledronate—Urinary tract disorder—Doxorubicin—breast cancer	2.66e-05	0.000137	CcSEcCtD
Zoledronate—Oedema peripheral—Doxorubicin—breast cancer	2.66e-05	0.000137	CcSEcCtD
Zoledronate—Dysgeusia—Methotrexate—breast cancer	2.66e-05	0.000137	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Docetaxel—breast cancer	2.65e-05	0.000136	CcSEcCtD
Zoledronate—Connective tissue disorder—Doxorubicin—breast cancer	2.65e-05	0.000136	CcSEcCtD
Zoledronate—Dyspnoea—Capecitabine—breast cancer	2.65e-05	0.000136	CcSEcCtD
Zoledronate—Fatigue—Docetaxel—breast cancer	2.65e-05	0.000136	CcSEcCtD
Zoledronate—Angiopathy—Epirubicin—breast cancer	2.64e-05	0.000136	CcSEcCtD
Zoledronate—Urethral disorder—Doxorubicin—breast cancer	2.64e-05	0.000136	CcSEcCtD
Zoledronate—Nausea—Irinotecan—breast cancer	2.64e-05	0.000136	CcSEcCtD
Zoledronate—Nausea—Mitoxantrone—breast cancer	2.64e-05	0.000136	CcSEcCtD
Zoledronate—Immune system disorder—Epirubicin—breast cancer	2.63e-05	0.000135	CcSEcCtD
Zoledronate—Mediastinal disorder—Epirubicin—breast cancer	2.63e-05	0.000135	CcSEcCtD
Zoledronate—Pain—Docetaxel—breast cancer	2.63e-05	0.000135	CcSEcCtD
Zoledronate—Constipation—Docetaxel—breast cancer	2.63e-05	0.000135	CcSEcCtD
Zoledronate—Back pain—Methotrexate—breast cancer	2.62e-05	0.000135	CcSEcCtD
Zoledronate—Dyspepsia—Capecitabine—breast cancer	2.62e-05	0.000135	CcSEcCtD
Zoledronate—Chills—Epirubicin—breast cancer	2.62e-05	0.000134	CcSEcCtD
Zoledronate—Arrhythmia—Epirubicin—breast cancer	2.6e-05	0.000134	CcSEcCtD
Zoledronate—Asthenia—Paclitaxel—breast cancer	2.6e-05	0.000134	CcSEcCtD
Zoledronate—Decreased appetite—Capecitabine—breast cancer	2.58e-05	0.000133	CcSEcCtD
Zoledronate—Alopecia—Epirubicin—breast cancer	2.58e-05	0.000132	CcSEcCtD
Zoledronate—Nausea—Gemcitabine—breast cancer	2.57e-05	0.000132	CcSEcCtD
Zoledronate—Gastrointestinal disorder—Capecitabine—breast cancer	2.57e-05	0.000132	CcSEcCtD
Zoledronate—Fatigue—Capecitabine—breast cancer	2.56e-05	0.000132	CcSEcCtD
Zoledronate—Pruritus—Paclitaxel—breast cancer	2.56e-05	0.000132	CcSEcCtD
Zoledronate—Vision blurred—Methotrexate—breast cancer	2.56e-05	0.000131	CcSEcCtD
Zoledronate—Mental disorder—Epirubicin—breast cancer	2.55e-05	0.000131	CcSEcCtD
Zoledronate—Pain—Capecitabine—breast cancer	2.54e-05	0.000131	CcSEcCtD
Zoledronate—Constipation—Capecitabine—breast cancer	2.54e-05	0.000131	CcSEcCtD
Zoledronate—Malnutrition—Epirubicin—breast cancer	2.54e-05	0.00013	CcSEcCtD
Zoledronate—Erythema—Epirubicin—breast cancer	2.54e-05	0.00013	CcSEcCtD
Zoledronate—Feeling abnormal—Docetaxel—breast cancer	2.53e-05	0.00013	CcSEcCtD
Zoledronate—Nausea—Fluorouracil—breast cancer	2.53e-05	0.00013	CcSEcCtD
Zoledronate—Eye disorder—Doxorubicin—breast cancer	2.52e-05	0.00013	CcSEcCtD
Zoledronate—Ill-defined disorder—Methotrexate—breast cancer	2.52e-05	0.000129	CcSEcCtD
Zoledronate—Gastrointestinal pain—Docetaxel—breast cancer	2.51e-05	0.000129	CcSEcCtD
Zoledronate—Anaemia—Methotrexate—breast cancer	2.51e-05	0.000129	CcSEcCtD
Zoledronate—Flushing—Doxorubicin—breast cancer	2.5e-05	0.000129	CcSEcCtD
Zoledronate—Cardiac disorder—Doxorubicin—breast cancer	2.5e-05	0.000129	CcSEcCtD
Zoledronate—Dysgeusia—Epirubicin—breast cancer	2.48e-05	0.000128	CcSEcCtD
Zoledronate—Diarrhoea—Paclitaxel—breast cancer	2.48e-05	0.000127	CcSEcCtD
Zoledronate—Back pain—Epirubicin—breast cancer	2.45e-05	0.000126	CcSEcCtD
Zoledronate—Feeling abnormal—Capecitabine—breast cancer	2.45e-05	0.000126	CcSEcCtD
Zoledronate—Angiopathy—Doxorubicin—breast cancer	2.45e-05	0.000126	CcSEcCtD
Zoledronate—Malaise—Methotrexate—breast cancer	2.45e-05	0.000126	CcSEcCtD
Zoledronate—Muscle spasms—Epirubicin—breast cancer	2.44e-05	0.000125	CcSEcCtD
Zoledronate—Immune system disorder—Doxorubicin—breast cancer	2.44e-05	0.000125	CcSEcCtD
Zoledronate—Vertigo—Methotrexate—breast cancer	2.44e-05	0.000125	CcSEcCtD
Zoledronate—Gastrointestinal pain—Capecitabine—breast cancer	2.43e-05	0.000125	CcSEcCtD
Zoledronate—Mediastinal disorder—Doxorubicin—breast cancer	2.43e-05	0.000125	CcSEcCtD
Zoledronate—Abdominal pain—Docetaxel—breast cancer	2.43e-05	0.000125	CcSEcCtD
Zoledronate—Body temperature increased—Docetaxel—breast cancer	2.43e-05	0.000125	CcSEcCtD
Zoledronate—Leukopenia—Methotrexate—breast cancer	2.43e-05	0.000125	CcSEcCtD
Zoledronate—Chills—Doxorubicin—breast cancer	2.42e-05	0.000124	CcSEcCtD
Zoledronate—Arrhythmia—Doxorubicin—breast cancer	2.41e-05	0.000124	CcSEcCtD
Zoledronate—Dizziness—Paclitaxel—breast cancer	2.4e-05	0.000123	CcSEcCtD
Zoledronate—Vision blurred—Epirubicin—breast cancer	2.39e-05	0.000123	CcSEcCtD
Zoledronate—Alopecia—Doxorubicin—breast cancer	2.38e-05	0.000123	CcSEcCtD
Zoledronate—Cough—Methotrexate—breast cancer	2.37e-05	0.000122	CcSEcCtD
Zoledronate—Mental disorder—Doxorubicin—breast cancer	2.36e-05	0.000121	CcSEcCtD
Zoledronate—Urticaria—Capecitabine—breast cancer	2.36e-05	0.000121	CcSEcCtD
Zoledronate—Ill-defined disorder—Epirubicin—breast cancer	2.35e-05	0.000121	CcSEcCtD
Zoledronate—Body temperature increased—Capecitabine—breast cancer	2.35e-05	0.000121	CcSEcCtD
Zoledronate—Abdominal pain—Capecitabine—breast cancer	2.35e-05	0.000121	CcSEcCtD
Zoledronate—Convulsion—Methotrexate—breast cancer	2.35e-05	0.000121	CcSEcCtD
Zoledronate—Malnutrition—Doxorubicin—breast cancer	2.35e-05	0.000121	CcSEcCtD
Zoledronate—Erythema—Doxorubicin—breast cancer	2.35e-05	0.000121	CcSEcCtD
Zoledronate—Anaemia—Epirubicin—breast cancer	2.35e-05	0.000121	CcSEcCtD
Zoledronate—Agitation—Epirubicin—breast cancer	2.33e-05	0.00012	CcSEcCtD
Zoledronate—Chest pain—Methotrexate—breast cancer	2.31e-05	0.000119	CcSEcCtD
Zoledronate—Arthralgia—Methotrexate—breast cancer	2.31e-05	0.000119	CcSEcCtD
Zoledronate—Myalgia—Methotrexate—breast cancer	2.31e-05	0.000119	CcSEcCtD
Zoledronate—Vomiting—Paclitaxel—breast cancer	2.3e-05	0.000118	CcSEcCtD
Zoledronate—Dysgeusia—Doxorubicin—breast cancer	2.3e-05	0.000118	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.29e-05	0.000118	CcSEcCtD
Zoledronate—Malaise—Epirubicin—breast cancer	2.29e-05	0.000118	CcSEcCtD
Zoledronate—Rash—Paclitaxel—breast cancer	2.28e-05	0.000117	CcSEcCtD
Zoledronate—Dermatitis—Paclitaxel—breast cancer	2.28e-05	0.000117	CcSEcCtD
Zoledronate—Discomfort—Methotrexate—breast cancer	2.28e-05	0.000117	CcSEcCtD
Zoledronate—Vertigo—Epirubicin—breast cancer	2.28e-05	0.000117	CcSEcCtD
Zoledronate—Syncope—Epirubicin—breast cancer	2.28e-05	0.000117	CcSEcCtD
Zoledronate—Leukopenia—Epirubicin—breast cancer	2.27e-05	0.000117	CcSEcCtD
Zoledronate—Back pain—Doxorubicin—breast cancer	2.27e-05	0.000117	CcSEcCtD
Zoledronate—Headache—Paclitaxel—breast cancer	2.27e-05	0.000117	CcSEcCtD
Zoledronate—Hypersensitivity—Docetaxel—breast cancer	2.26e-05	0.000116	CcSEcCtD
Zoledronate—Muscle spasms—Doxorubicin—breast cancer	2.26e-05	0.000116	CcSEcCtD
Zoledronate—Palpitations—Epirubicin—breast cancer	2.24e-05	0.000115	CcSEcCtD
Zoledronate—Confusional state—Methotrexate—breast cancer	2.23e-05	0.000115	CcSEcCtD
Zoledronate—Loss of consciousness—Epirubicin—breast cancer	2.23e-05	0.000115	CcSEcCtD
Zoledronate—Cough—Epirubicin—breast cancer	2.21e-05	0.000114	CcSEcCtD
Zoledronate—Anaphylactic shock—Methotrexate—breast cancer	2.21e-05	0.000114	CcSEcCtD
Zoledronate—Vision blurred—Doxorubicin—breast cancer	2.21e-05	0.000114	CcSEcCtD
Zoledronate—Asthenia—Docetaxel—breast cancer	2.2e-05	0.000113	CcSEcCtD
Zoledronate—Convulsion—Epirubicin—breast cancer	2.2e-05	0.000113	CcSEcCtD
Zoledronate—Infection—Methotrexate—breast cancer	2.2e-05	0.000113	CcSEcCtD
Zoledronate—Hypertension—Epirubicin—breast cancer	2.19e-05	0.000113	CcSEcCtD
Zoledronate—Hypersensitivity—Capecitabine—breast cancer	2.19e-05	0.000113	CcSEcCtD
Zoledronate—Ill-defined disorder—Doxorubicin—breast cancer	2.18e-05	0.000112	CcSEcCtD
Zoledronate—Pruritus—Docetaxel—breast cancer	2.17e-05	0.000112	CcSEcCtD
Zoledronate—Nervous system disorder—Methotrexate—breast cancer	2.17e-05	0.000112	CcSEcCtD
Zoledronate—Anaemia—Doxorubicin—breast cancer	2.17e-05	0.000112	CcSEcCtD
Zoledronate—Thrombocytopenia—Methotrexate—breast cancer	2.17e-05	0.000111	CcSEcCtD
Zoledronate—Chest pain—Epirubicin—breast cancer	2.16e-05	0.000111	CcSEcCtD
Zoledronate—Arthralgia—Epirubicin—breast cancer	2.16e-05	0.000111	CcSEcCtD
Zoledronate—Myalgia—Epirubicin—breast cancer	2.16e-05	0.000111	CcSEcCtD
Zoledronate—Agitation—Doxorubicin—breast cancer	2.16e-05	0.000111	CcSEcCtD
Zoledronate—Anxiety—Epirubicin—breast cancer	2.15e-05	0.000111	CcSEcCtD
Zoledronate—Nausea—Paclitaxel—breast cancer	2.15e-05	0.000111	CcSEcCtD
Zoledronate—Skin disorder—Methotrexate—breast cancer	2.15e-05	0.000111	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.15e-05	0.00011	CcSEcCtD
Zoledronate—Hyperhidrosis—Methotrexate—breast cancer	2.14e-05	0.00011	CcSEcCtD
Zoledronate—Discomfort—Epirubicin—breast cancer	2.13e-05	0.00011	CcSEcCtD
Zoledronate—Asthenia—Capecitabine—breast cancer	2.13e-05	0.00011	CcSEcCtD
Zoledronate—Malaise—Doxorubicin—breast cancer	2.12e-05	0.000109	CcSEcCtD
Zoledronate—Dry mouth—Epirubicin—breast cancer	2.11e-05	0.000109	CcSEcCtD
Zoledronate—Vertigo—Doxorubicin—breast cancer	2.11e-05	0.000108	CcSEcCtD
Zoledronate—Anorexia—Methotrexate—breast cancer	2.11e-05	0.000108	CcSEcCtD
Zoledronate—Syncope—Doxorubicin—breast cancer	2.11e-05	0.000108	CcSEcCtD
Zoledronate—Pruritus—Capecitabine—breast cancer	2.1e-05	0.000108	CcSEcCtD
Zoledronate—Leukopenia—Doxorubicin—breast cancer	2.1e-05	0.000108	CcSEcCtD
Zoledronate—Diarrhoea—Docetaxel—breast cancer	2.1e-05	0.000108	CcSEcCtD
Zoledronate—Confusional state—Epirubicin—breast cancer	2.09e-05	0.000107	CcSEcCtD
Zoledronate—CA2—Metabolism—SLC2A1—breast cancer	2.08e-05	0.000343	CbGpPWpGaD
Zoledronate—Palpitations—Doxorubicin—breast cancer	2.07e-05	0.000107	CcSEcCtD
Zoledronate—Anaphylactic shock—Epirubicin—breast cancer	2.07e-05	0.000106	CcSEcCtD
Zoledronate—Oedema—Epirubicin—breast cancer	2.07e-05	0.000106	CcSEcCtD
Zoledronate—FDPS—Metabolism—GPX1—breast cancer	2.07e-05	0.000342	CbGpPWpGaD
Zoledronate—Hypotension—Methotrexate—breast cancer	2.07e-05	0.000106	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	2.07e-05	0.000341	CbGpPWpGaD
Zoledronate—Loss of consciousness—Doxorubicin—breast cancer	2.06e-05	0.000106	CcSEcCtD
Zoledronate—ABCC1—Disease—ELL—breast cancer	2.06e-05	0.00034	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ALDH7A1—breast cancer	2.06e-05	0.00034	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ALDH1A1—breast cancer	2.06e-05	0.00034	CbGpPWpGaD
Zoledronate—Infection—Epirubicin—breast cancer	2.06e-05	0.000106	CcSEcCtD
Zoledronate—FDPS—Metabolism—CYP1A1—breast cancer	2.05e-05	0.000338	CbGpPWpGaD
Zoledronate—Cough—Doxorubicin—breast cancer	2.05e-05	0.000105	CcSEcCtD
Zoledronate—Shock—Epirubicin—breast cancer	2.04e-05	0.000105	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	2.04e-05	0.000336	CbGpPWpGaD
Zoledronate—Convulsion—Doxorubicin—breast cancer	2.03e-05	0.000105	CcSEcCtD
Zoledronate—Diarrhoea—Capecitabine—breast cancer	2.03e-05	0.000105	CcSEcCtD
Zoledronate—FDPS—Metabolism—ERCC2—breast cancer	2.03e-05	0.000336	CbGpPWpGaD
Zoledronate—Nervous system disorder—Epirubicin—breast cancer	2.03e-05	0.000104	CcSEcCtD
Zoledronate—Dizziness—Docetaxel—breast cancer	2.03e-05	0.000104	CcSEcCtD
Zoledronate—Thrombocytopenia—Epirubicin—breast cancer	2.03e-05	0.000104	CcSEcCtD
Zoledronate—CA2—Metabolism—CYP3A4—breast cancer	2.03e-05	0.000335	CbGpPWpGaD
Zoledronate—Hypertension—Doxorubicin—breast cancer	2.03e-05	0.000104	CcSEcCtD
Zoledronate—Tachycardia—Epirubicin—breast cancer	2.02e-05	0.000104	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Methotrexate—breast cancer	2.02e-05	0.000104	CcSEcCtD
Zoledronate—CA14—Metabolism—CAV1—breast cancer	2.02e-05	0.000333	CbGpPWpGaD
Zoledronate—Skin disorder—Epirubicin—breast cancer	2.01e-05	0.000103	CcSEcCtD
Zoledronate—Hyperhidrosis—Epirubicin—breast cancer	2e-05	0.000103	CcSEcCtD
Zoledronate—Insomnia—Methotrexate—breast cancer	2e-05	0.000103	CcSEcCtD
Zoledronate—Arthralgia—Doxorubicin—breast cancer	2e-05	0.000103	CcSEcCtD
Zoledronate—Chest pain—Doxorubicin—breast cancer	2e-05	0.000103	CcSEcCtD
Zoledronate—Myalgia—Doxorubicin—breast cancer	2e-05	0.000103	CcSEcCtD
Zoledronate—CA12—Metabolism—GPX1—breast cancer	2e-05	0.00033	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CYP1B1—breast cancer	1.99e-05	0.000329	CbGpPWpGaD
Zoledronate—Anxiety—Doxorubicin—breast cancer	1.99e-05	0.000102	CcSEcCtD
Zoledronate—Paraesthesia—Methotrexate—breast cancer	1.99e-05	0.000102	CcSEcCtD
Zoledronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.99e-05	0.000102	CcSEcCtD
Zoledronate—ABCC1—Metabolism—NME1—breast cancer	1.98e-05	0.000326	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—UMPS—breast cancer	1.98e-05	0.000326	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—FHL2—breast cancer	1.98e-05	0.000326	CbGpPWpGaD
Zoledronate—CA12—Metabolism—CYP1A1—breast cancer	1.98e-05	0.000326	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ADSL—breast cancer	1.98e-05	0.000326	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PHGDH—breast cancer	1.98e-05	0.000326	CbGpPWpGaD
Zoledronate—Discomfort—Doxorubicin—breast cancer	1.97e-05	0.000102	CcSEcCtD
Zoledronate—Anorexia—Epirubicin—breast cancer	1.97e-05	0.000102	CcSEcCtD
Zoledronate—Dyspnoea—Methotrexate—breast cancer	1.97e-05	0.000101	CcSEcCtD
Zoledronate—Somnolence—Methotrexate—breast cancer	1.97e-05	0.000101	CcSEcCtD
Zoledronate—Dizziness—Capecitabine—breast cancer	1.97e-05	0.000101	CcSEcCtD
Zoledronate—ABCC1—Transmembrane transport of small molecules—NCOA1—breast cancer	1.97e-05	0.000324	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ERCC2—breast cancer	1.96e-05	0.000324	CbGpPWpGaD
Zoledronate—Dry mouth—Doxorubicin—breast cancer	1.95e-05	0.000101	CcSEcCtD
Zoledronate—CA2—Metabolism—HSP90AA1—breast cancer	1.95e-05	0.000323	CbGpPWpGaD
Zoledronate—Vomiting—Docetaxel—breast cancer	1.95e-05	0.0001	CcSEcCtD
Zoledronate—Dyspepsia—Methotrexate—breast cancer	1.95e-05	0.0001	CcSEcCtD
Zoledronate—ABCC1—Metabolism—HPSE—breast cancer	1.94e-05	0.00032	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—LDHB—breast cancer	1.94e-05	0.00032	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—BRIP1—breast cancer	1.94e-05	0.00032	CbGpPWpGaD
Zoledronate—Rash—Docetaxel—breast cancer	1.94e-05	9.95e-05	CcSEcCtD
Zoledronate—Hypotension—Epirubicin—breast cancer	1.94e-05	9.95e-05	CcSEcCtD
Zoledronate—Dermatitis—Docetaxel—breast cancer	1.93e-05	9.94e-05	CcSEcCtD
Zoledronate—Confusional state—Doxorubicin—breast cancer	1.93e-05	9.93e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—HEY2—breast cancer	1.93e-05	0.000319	CbGpPWpGaD
Zoledronate—Decreased appetite—Methotrexate—breast cancer	1.92e-05	9.89e-05	CcSEcCtD
Zoledronate—Headache—Docetaxel—breast cancer	1.92e-05	9.89e-05	CcSEcCtD
Zoledronate—Anaphylactic shock—Doxorubicin—breast cancer	1.92e-05	9.85e-05	CcSEcCtD
Zoledronate—Oedema—Doxorubicin—breast cancer	1.92e-05	9.85e-05	CcSEcCtD
Zoledronate—ABCC1—Transmembrane transport of small molecules—PLG—breast cancer	1.92e-05	0.000316	CbGpPWpGaD
Zoledronate—Gastrointestinal disorder—Methotrexate—breast cancer	1.91e-05	9.82e-05	CcSEcCtD
Zoledronate—FDPS—Metabolism—MTHFR—breast cancer	1.91e-05	0.000315	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RPS6KB2—breast cancer	1.91e-05	0.000315	CbGpPWpGaD
Zoledronate—Fatigue—Methotrexate—breast cancer	1.91e-05	9.81e-05	CcSEcCtD
Zoledronate—Infection—Doxorubicin—breast cancer	1.9e-05	9.79e-05	CcSEcCtD
Zoledronate—CA2—Metabolism—NCOA1—breast cancer	1.9e-05	0.000314	CbGpPWpGaD
Zoledronate—Pain—Methotrexate—breast cancer	1.89e-05	9.73e-05	CcSEcCtD
Zoledronate—Vomiting—Capecitabine—breast cancer	1.89e-05	9.72e-05	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Epirubicin—breast cancer	1.89e-05	9.7e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—IDH1—breast cancer	1.89e-05	0.000311	CbGpPWpGaD
Zoledronate—Shock—Doxorubicin—breast cancer	1.89e-05	9.69e-05	CcSEcCtD
Zoledronate—Nervous system disorder—Doxorubicin—breast cancer	1.88e-05	9.66e-05	CcSEcCtD
Zoledronate—Thrombocytopenia—Doxorubicin—breast cancer	1.88e-05	9.65e-05	CcSEcCtD
Zoledronate—Rash—Capecitabine—breast cancer	1.87e-05	9.64e-05	CcSEcCtD
Zoledronate—CA2—Metabolism—CYP19A1—breast cancer	1.87e-05	0.000309	CbGpPWpGaD
Zoledronate—CA2—Metabolism—STK11—breast cancer	1.87e-05	0.000309	CbGpPWpGaD
Zoledronate—Insomnia—Epirubicin—breast cancer	1.87e-05	9.63e-05	CcSEcCtD
Zoledronate—Dermatitis—Capecitabine—breast cancer	1.87e-05	9.63e-05	CcSEcCtD
Zoledronate—Tachycardia—Doxorubicin—breast cancer	1.87e-05	9.62e-05	CcSEcCtD
Zoledronate—Headache—Capecitabine—breast cancer	1.86e-05	9.58e-05	CcSEcCtD
Zoledronate—Skin disorder—Doxorubicin—breast cancer	1.86e-05	9.57e-05	CcSEcCtD
Zoledronate—Paraesthesia—Epirubicin—breast cancer	1.86e-05	9.56e-05	CcSEcCtD
Zoledronate—Hyperhidrosis—Doxorubicin—breast cancer	1.85e-05	9.52e-05	CcSEcCtD
Zoledronate—Dyspnoea—Epirubicin—breast cancer	1.85e-05	9.49e-05	CcSEcCtD
Zoledronate—CA12—Metabolism—MTHFR—breast cancer	1.84e-05	0.000304	CbGpPWpGaD
Zoledronate—Somnolence—Epirubicin—breast cancer	1.84e-05	9.47e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—GSTA3—breast cancer	1.84e-05	0.000303	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HMMR—breast cancer	1.84e-05	0.000303	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CG—breast cancer	1.84e-05	0.000303	CbGpPWpGaD
Zoledronate—Anorexia—Doxorubicin—breast cancer	1.83e-05	9.39e-05	CcSEcCtD
Zoledronate—Nausea—Docetaxel—breast cancer	1.82e-05	9.38e-05	CcSEcCtD
Zoledronate—Feeling abnormal—Methotrexate—breast cancer	1.82e-05	9.38e-05	CcSEcCtD
Zoledronate—Dyspepsia—Epirubicin—breast cancer	1.82e-05	9.37e-05	CcSEcCtD
Zoledronate—Gastrointestinal pain—Methotrexate—breast cancer	1.81e-05	9.3e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—TLE3—breast cancer	1.81e-05	0.000298	CbGpPWpGaD
Zoledronate—Decreased appetite—Epirubicin—breast cancer	1.8e-05	9.26e-05	CcSEcCtD
Zoledronate—Hypotension—Doxorubicin—breast cancer	1.79e-05	9.21e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—HEY1—breast cancer	1.79e-05	0.000295	CbGpPWpGaD
Zoledronate—Gastrointestinal disorder—Epirubicin—breast cancer	1.79e-05	9.19e-05	CcSEcCtD
Zoledronate—Fatigue—Epirubicin—breast cancer	1.79e-05	9.18e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—PPARGC1B—breast cancer	1.78e-05	0.000294	CbGpPWpGaD
Zoledronate—Constipation—Epirubicin—breast cancer	1.77e-05	9.11e-05	CcSEcCtD
Zoledronate—Pain—Epirubicin—breast cancer	1.77e-05	9.11e-05	CcSEcCtD
Zoledronate—ABCC1—Transmembrane transport of small molecules—HMOX1—breast cancer	1.77e-05	0.000292	CbGpPWpGaD
Zoledronate—Nausea—Capecitabine—breast cancer	1.77e-05	9.08e-05	CcSEcCtD
Zoledronate—FDPS—Metabolism—CAV1—breast cancer	1.76e-05	0.000291	CbGpPWpGaD
Zoledronate—Urticaria—Methotrexate—breast cancer	1.76e-05	9.04e-05	CcSEcCtD
Zoledronate—GGPS1—Metabolism—PIK3CA—breast cancer	1.76e-05	0.00029	CbGpPWpGaD
Zoledronate—ABCC1—Disease—DLL1—breast cancer	1.75e-05	0.000289	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RPL23A—breast cancer	1.75e-05	0.000289	CbGpPWpGaD
Zoledronate—Body temperature increased—Methotrexate—breast cancer	1.75e-05	8.99e-05	CcSEcCtD
Zoledronate—Abdominal pain—Methotrexate—breast cancer	1.75e-05	8.99e-05	CcSEcCtD
Zoledronate—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.75e-05	8.98e-05	CcSEcCtD
Zoledronate—CA2—Metabolism—COMT—breast cancer	1.74e-05	0.000288	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GSTP1—breast cancer	1.73e-05	0.000286	CbGpPWpGaD
Zoledronate—Insomnia—Doxorubicin—breast cancer	1.73e-05	8.91e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.73e-05	0.000286	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.73e-05	0.000286	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HIST1H2BC—breast cancer	1.72e-05	0.000284	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MAP2K7—breast cancer	1.72e-05	0.000284	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HIST1H2BK—breast cancer	1.72e-05	0.000284	CbGpPWpGaD
Zoledronate—Paraesthesia—Doxorubicin—breast cancer	1.72e-05	8.85e-05	CcSEcCtD
Zoledronate—CA2—Metabolism—HMOX1—breast cancer	1.71e-05	0.000282	CbGpPWpGaD
Zoledronate—Dyspnoea—Doxorubicin—breast cancer	1.71e-05	8.78e-05	CcSEcCtD
Zoledronate—Feeling abnormal—Epirubicin—breast cancer	1.71e-05	8.77e-05	CcSEcCtD
Zoledronate—CA2—Metabolism—ITPR1—breast cancer	1.71e-05	0.000282	CbGpPWpGaD
Zoledronate—Somnolence—Doxorubicin—breast cancer	1.7e-05	8.76e-05	CcSEcCtD
Zoledronate—CA12—Metabolism—CAV1—breast cancer	1.7e-05	0.000281	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ABCB1—breast cancer	1.7e-05	0.00028	CbGpPWpGaD
Zoledronate—Gastrointestinal pain—Epirubicin—breast cancer	1.69e-05	8.71e-05	CcSEcCtD
Zoledronate—Dyspepsia—Doxorubicin—breast cancer	1.69e-05	8.67e-05	CcSEcCtD
Zoledronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.68e-05	0.000278	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CA9—breast cancer	1.68e-05	0.000277	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTA4—breast cancer	1.68e-05	0.000277	CbGpPWpGaD
Zoledronate—Decreased appetite—Doxorubicin—breast cancer	1.67e-05	8.56e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.66e-05	0.000274	CbGpPWpGaD
Zoledronate—Gastrointestinal disorder—Doxorubicin—breast cancer	1.65e-05	8.51e-05	CcSEcCtD
Zoledronate—Fatigue—Doxorubicin—breast cancer	1.65e-05	8.49e-05	CcSEcCtD
Zoledronate—Urticaria—Epirubicin—breast cancer	1.65e-05	8.46e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.64e-05	0.000271	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ABCB1—breast cancer	1.64e-05	0.000271	CbGpPWpGaD
Zoledronate—Constipation—Doxorubicin—breast cancer	1.64e-05	8.43e-05	CcSEcCtD
Zoledronate—Pain—Doxorubicin—breast cancer	1.64e-05	8.43e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—GSTA2—breast cancer	1.64e-05	0.00027	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GPX2—breast cancer	1.64e-05	0.00027	CbGpPWpGaD
Zoledronate—Abdominal pain—Epirubicin—breast cancer	1.64e-05	8.42e-05	CcSEcCtD
Zoledronate—Body temperature increased—Epirubicin—breast cancer	1.64e-05	8.42e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—RPS8—breast cancer	1.64e-05	0.00027	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RPS7—breast cancer	1.64e-05	0.00027	CbGpPWpGaD
Zoledronate—Hypersensitivity—Methotrexate—breast cancer	1.63e-05	8.38e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—DKK1—breast cancer	1.62e-05	0.000268	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GPX4—breast cancer	1.62e-05	0.000267	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SULT1A1—breast cancer	1.62e-05	0.000267	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CD—breast cancer	1.61e-05	0.000266	CbGpPWpGaD
Zoledronate—CA2—Metabolism—TYMS—breast cancer	1.61e-05	0.000266	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ALDOA—breast cancer	1.61e-05	0.000266	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CG—breast cancer	1.6e-05	0.000265	CbGpPWpGaD
Zoledronate—CA2—Metabolism—NCOR1—breast cancer	1.59e-05	0.000263	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PLA2G4A—breast cancer	1.59e-05	0.000263	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GSTM1—breast cancer	1.59e-05	0.000263	CbGpPWpGaD
Zoledronate—CA14—Metabolism—ALB—breast cancer	1.59e-05	0.000263	CbGpPWpGaD
Zoledronate—Asthenia—Methotrexate—breast cancer	1.59e-05	8.16e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—JAG2—breast cancer	1.59e-05	0.000262	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTA1—breast cancer	1.58e-05	0.000261	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—IDH1—breast cancer	1.58e-05	0.000261	CbGpPWpGaD
Zoledronate—Feeling abnormal—Doxorubicin—breast cancer	1.58e-05	8.12e-05	CcSEcCtD
Zoledronate—Gastrointestinal pain—Doxorubicin—breast cancer	1.57e-05	8.06e-05	CcSEcCtD
Zoledronate—Pruritus—Methotrexate—breast cancer	1.57e-05	8.05e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—WNT1—breast cancer	1.56e-05	0.000258	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NAT2—breast cancer	1.56e-05	0.000258	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SLC2A2—breast cancer	1.55e-05	0.000256	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CG—breast cancer	1.55e-05	0.000256	CbGpPWpGaD
Zoledronate—CA2—Metabolism—GPX1—breast cancer	1.53e-05	0.000252	CbGpPWpGaD
Zoledronate—Hypersensitivity—Epirubicin—breast cancer	1.53e-05	7.85e-05	CcSEcCtD
Zoledronate—CA14—Metabolism—NOS3—breast cancer	1.52e-05	0.000252	CbGpPWpGaD
Zoledronate—Urticaria—Doxorubicin—breast cancer	1.52e-05	7.83e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—MTR—breast cancer	1.52e-05	0.000251	CbGpPWpGaD
Zoledronate—Abdominal pain—Doxorubicin—breast cancer	1.51e-05	7.79e-05	CcSEcCtD
Zoledronate—Body temperature increased—Doxorubicin—breast cancer	1.51e-05	7.79e-05	CcSEcCtD
Zoledronate—Diarrhoea—Methotrexate—breast cancer	1.51e-05	7.79e-05	CcSEcCtD
Zoledronate—CA2—Metabolism—CYP1A1—breast cancer	1.51e-05	0.000249	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ERCC2—breast cancer	1.5e-05	0.000247	CbGpPWpGaD
Zoledronate—Asthenia—Epirubicin—breast cancer	1.49e-05	7.64e-05	CcSEcCtD
Zoledronate—Pruritus—Epirubicin—breast cancer	1.47e-05	7.53e-05	CcSEcCtD
Zoledronate—Dizziness—Methotrexate—breast cancer	1.46e-05	7.52e-05	CcSEcCtD
Zoledronate—GGPS1—Metabolism—AKT1—breast cancer	1.43e-05	0.000237	CbGpPWpGaD
Zoledronate—Diarrhoea—Epirubicin—breast cancer	1.42e-05	7.29e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—HSPA1B—breast cancer	1.41e-05	0.000233	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.41e-05	0.000233	CbGpPWpGaD
Zoledronate—Hypersensitivity—Doxorubicin—breast cancer	1.41e-05	7.26e-05	CcSEcCtD
Zoledronate—FDPS—Metabolism—PIK3CD—breast cancer	1.41e-05	0.000233	CbGpPWpGaD
Zoledronate—CA2—Metabolism—MTHFR—breast cancer	1.41e-05	0.000233	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CB—breast cancer	1.41e-05	0.000232	CbGpPWpGaD
Zoledronate—Vomiting—Methotrexate—breast cancer	1.41e-05	7.23e-05	CcSEcCtD
Zoledronate—Rash—Methotrexate—breast cancer	1.4e-05	7.17e-05	CcSEcCtD
Zoledronate—CA14—Metabolism—PTGS2—breast cancer	1.39e-05	0.00023	CbGpPWpGaD
Zoledronate—Dermatitis—Methotrexate—breast cancer	1.39e-05	7.17e-05	CcSEcCtD
Zoledronate—FDPS—Metabolism—ALB—breast cancer	1.39e-05	0.00023	CbGpPWpGaD
Zoledronate—Headache—Methotrexate—breast cancer	1.39e-05	7.13e-05	CcSEcCtD
Zoledronate—Asthenia—Doxorubicin—breast cancer	1.37e-05	7.07e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—MED12—breast cancer	1.37e-05	0.000226	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—DPYD—breast cancer	1.37e-05	0.000226	CbGpPWpGaD
Zoledronate—Dizziness—Epirubicin—breast cancer	1.37e-05	7.04e-05	CcSEcCtD
Zoledronate—CA12—Metabolism—PIK3CD—breast cancer	1.36e-05	0.000225	CbGpPWpGaD
Zoledronate—Pruritus—Doxorubicin—breast cancer	1.36e-05	6.97e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—ENO1—breast cancer	1.36e-05	0.000224	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ALDOA—breast cancer	1.35e-05	0.000223	CbGpPWpGaD
Zoledronate—CA12—Metabolism—ALB—breast cancer	1.34e-05	0.000222	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—NOS3—breast cancer	1.33e-05	0.00022	CbGpPWpGaD
Zoledronate—Vomiting—Epirubicin—breast cancer	1.32e-05	6.77e-05	CcSEcCtD
Zoledronate—Nausea—Methotrexate—breast cancer	1.31e-05	6.76e-05	CcSEcCtD
Zoledronate—Diarrhoea—Doxorubicin—breast cancer	1.31e-05	6.74e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—NCOA3—breast cancer	1.31e-05	0.000216	CbGpPWpGaD
Zoledronate—Rash—Epirubicin—breast cancer	1.31e-05	6.71e-05	CcSEcCtD
Zoledronate—Dermatitis—Epirubicin—breast cancer	1.3e-05	6.71e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—SLC2A2—breast cancer	1.3e-05	0.000215	CbGpPWpGaD
Zoledronate—CA2—Metabolism—CAV1—breast cancer	1.3e-05	0.000214	CbGpPWpGaD
Zoledronate—Headache—Epirubicin—breast cancer	1.3e-05	6.67e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.29e-05	0.000212	CbGpPWpGaD
Zoledronate—CA12—Metabolism—NOS3—breast cancer	1.28e-05	0.000212	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FGF3—breast cancer	1.28e-05	0.000212	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ABCG2—breast cancer	1.27e-05	0.00021	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—MTR—breast cancer	1.27e-05	0.00021	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CPT1A—breast cancer	1.27e-05	0.00021	CbGpPWpGaD
Zoledronate—Dizziness—Doxorubicin—breast cancer	1.27e-05	6.52e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—JAG1—breast cancer	1.27e-05	0.000209	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FASN—breast cancer	1.27e-05	0.000209	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PARP1—breast cancer	1.26e-05	0.000208	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HPGDS—breast cancer	1.25e-05	0.000206	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CALCA—breast cancer	1.24e-05	0.000205	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HBA1—breast cancer	1.24e-05	0.000205	CbGpPWpGaD
Zoledronate—Nausea—Epirubicin—breast cancer	1.23e-05	6.33e-05	CcSEcCtD
Zoledronate—FDPS—Metabolism—PIK3CB—breast cancer	1.23e-05	0.000203	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RPS6—breast cancer	1.23e-05	0.000203	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FGF4—breast cancer	1.22e-05	0.000201	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PTGS2—breast cancer	1.22e-05	0.000201	CbGpPWpGaD
Zoledronate—Vomiting—Doxorubicin—breast cancer	1.22e-05	6.26e-05	CcSEcCtD
Zoledronate—CA14—Metabolism—PTEN—breast cancer	1.22e-05	0.000201	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CXCR4—breast cancer	1.22e-05	0.000201	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ACHE—breast cancer	1.21e-05	0.0002	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTT1—breast cancer	1.21e-05	0.0002	CbGpPWpGaD
Zoledronate—Rash—Doxorubicin—breast cancer	1.21e-05	6.21e-05	CcSEcCtD
Zoledronate—Dermatitis—Doxorubicin—breast cancer	1.21e-05	6.21e-05	CcSEcCtD
Zoledronate—ABCC1—Disease—SLC2A1—breast cancer	1.2e-05	0.000198	CbGpPWpGaD
Zoledronate—Headache—Doxorubicin—breast cancer	1.2e-05	6.17e-05	CcSEcCtD
Zoledronate—CA12—Metabolism—PIK3CB—breast cancer	1.19e-05	0.000196	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CG—breast cancer	1.18e-05	0.000195	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PTGS2—breast cancer	1.18e-05	0.000194	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TCF7L2—breast cancer	1.17e-05	0.000193	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP17A1—breast cancer	1.15e-05	0.000189	CbGpPWpGaD
Zoledronate—Nausea—Doxorubicin—breast cancer	1.14e-05	5.85e-05	CcSEcCtD
Zoledronate—ABCC1—Metabolism—ENO1—breast cancer	1.13e-05	0.000187	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PTGS1—breast cancer	1.13e-05	0.000187	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.13e-05	0.000187	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HSP90AA1—breast cancer	1.13e-05	0.000187	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.12e-05	0.000184	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP2D6—breast cancer	1.11e-05	0.000184	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PRL—breast cancer	1.1e-05	0.000181	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NCOA2—breast cancer	1.09e-05	0.00018	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ADAM10—breast cancer	1.08e-05	0.000179	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PTEN—breast cancer	1.06e-05	0.000175	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—ALB—breast cancer	1.06e-05	0.000175	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—FASN—breast cancer	1.06e-05	0.000175	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—BCHE—breast cancer	1.05e-05	0.000174	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FGF10—breast cancer	1.05e-05	0.000174	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SLC5A5—breast cancer	1.04e-05	0.000172	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CD—breast cancer	1.04e-05	0.000172	CbGpPWpGaD
Zoledronate—CA2—Metabolism—ALB—breast cancer	1.03e-05	0.00017	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PTEN—breast cancer	1.02e-05	0.000169	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PDGFA—breast cancer	1.02e-05	0.000168	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NQO1—breast cancer	1.01e-05	0.000166	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—SLC2A1—breast cancer	1.01e-05	0.000166	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TGFBR2—breast cancer	1e-05	0.000165	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ITPR1—breast cancer	9.86e-06	0.000163	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	9.86e-06	0.000163	CbGpPWpGaD
Zoledronate—CA2—Metabolism—NOS3—breast cancer	9.82e-06	0.000162	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP3A4—breast cancer	9.81e-06	0.000162	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ERBB4—breast cancer	9.8e-06	0.000162	CbGpPWpGaD
Zoledronate—ABCC1—Disease—STAT5A—breast cancer	9.8e-06	0.000162	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	9.76e-06	0.000161	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP1B1—breast cancer	9.65e-06	0.000159	CbGpPWpGaD
Zoledronate—ABCC1—Transmembrane transport of small molecules—RAF1—breast cancer	9.6e-06	0.000158	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SMAD4—breast cancer	9.49e-06	0.000157	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HSP90AA1—breast cancer	9.46e-06	0.000156	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HES1—breast cancer	9.26e-06	0.000153	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NCOR1—breast cancer	9.21e-06	0.000152	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NCOA1—breast cancer	9.21e-06	0.000152	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FGF1—breast cancer	9.11e-06	0.00015	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—STK11—breast cancer	9.07e-06	0.00015	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP19A1—breast cancer	9.07e-06	0.00015	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CB—breast cancer	9.07e-06	0.00015	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NRG1—breast cancer	9.04e-06	0.000149	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PTGS2—breast cancer	8.98e-06	0.000148	CbGpPWpGaD
Zoledronate—ABCC1—Disease—H2AFX—breast cancer	8.98e-06	0.000148	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ERCC2—breast cancer	8.66e-06	0.000143	CbGpPWpGaD
Zoledronate—CA14—Metabolism—PIK3CA—breast cancer	8.58e-06	0.000142	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	8.52e-06	0.000141	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ERBB3—breast cancer	8.47e-06	0.00014	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FGFR2—breast cancer	8.46e-06	0.00014	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—COMT—breast cancer	8.43e-06	0.000139	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTP1—breast cancer	8.39e-06	0.000139	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—HMOX1—breast cancer	8.28e-06	0.000137	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ITPR1—breast cancer	8.26e-06	0.000136	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MTHFR—breast cancer	8.14e-06	0.000134	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TERT—breast cancer	8.12e-06	0.000134	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ABCB1—breast cancer	7.95e-06	0.000131	CbGpPWpGaD
Zoledronate—ABCC1—Disease—FGFR1—breast cancer	7.88e-06	0.00013	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PTEN—breast cancer	7.83e-06	0.000129	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—TYMS—breast cancer	7.8e-06	0.000129	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HIF1A—breast cancer	7.76e-06	0.000128	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GSTM1—breast cancer	7.71e-06	0.000127	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NCOR1—breast cancer	7.71e-06	0.000127	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PLA2G4A—breast cancer	7.71e-06	0.000127	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CAV1—breast cancer	7.51e-06	0.000124	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—PIK3CA—breast cancer	7.5e-06	0.000124	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—GPX1—breast cancer	7.39e-06	0.000122	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CYP1A1—breast cancer	7.31e-06	0.000121	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ERCC2—breast cancer	7.25e-06	0.00012	CbGpPWpGaD
Zoledronate—CA12—Metabolism—PIK3CA—breast cancer	7.23e-06	0.000119	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NOS2—breast cancer	7.06e-06	0.000117	CbGpPWpGaD
Zoledronate—CA14—Metabolism—AKT1—breast cancer	7.01e-06	0.000116	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NOTCH1—breast cancer	6.99e-06	0.000115	CbGpPWpGaD
Zoledronate—ABCC1—Disease—APC—breast cancer	6.84e-06	0.000113	CbGpPWpGaD
Zoledronate—ABCC1—Disease—KIT—breast cancer	6.84e-06	0.000113	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—MTHFR—breast cancer	6.82e-06	0.000113	CbGpPWpGaD
Zoledronate—ABCC1—Disease—EGF—breast cancer	6.76e-06	0.000112	CbGpPWpGaD
Zoledronate—ABCC1—Disease—BRAF—breast cancer	6.43e-06	0.000106	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—CAV1—breast cancer	6.29e-06	0.000104	CbGpPWpGaD
Zoledronate—ABCC1—Disease—AKT2—breast cancer	6.26e-06	0.000103	CbGpPWpGaD
Zoledronate—FDPS—Metabolism—AKT1—breast cancer	6.12e-06	0.000101	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3CD—breast cancer	6.01e-06	9.93e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	6.01e-06	9.92e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SERPINE1—breast cancer	5.95e-06	9.82e-05	CbGpPWpGaD
Zoledronate—CA12—Metabolism—AKT1—breast cancer	5.91e-06	9.75e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CG—breast cancer	5.73e-06	9.46e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—NOS3—breast cancer	5.68e-06	9.37e-05	CbGpPWpGaD
Zoledronate—CA2—Metabolism—PIK3CA—breast cancer	5.53e-06	9.12e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MDM2—breast cancer	5.39e-06	8.89e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—RAF1—breast cancer	5.37e-06	8.86e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—ERBB2—breast cancer	5.31e-06	8.77e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MTOR—breast cancer	5.24e-06	8.65e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3CB—breast cancer	5.24e-06	8.65e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CD4—breast cancer	5.23e-06	8.64e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PTGS2—breast cancer	5.19e-06	8.57e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CD—breast cancer	5.04e-06	8.31e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—ALB—breast cancer	4.97e-06	8.21e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CDKN1B—breast cancer	4.92e-06	8.12e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—NOS3—breast cancer	4.75e-06	7.85e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CTNNB1—breast cancer	4.65e-06	7.67e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—CDKN1A—breast cancer	4.54e-06	7.49e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PTEN—breast cancer	4.53e-06	7.48e-05	CbGpPWpGaD
Zoledronate—CA2—Metabolism—AKT1—breast cancer	4.52e-06	7.45e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CB—breast cancer	4.39e-06	7.25e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PTGS2—breast cancer	4.35e-06	7.18e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—SRC—breast cancer	4.2e-06	6.93e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—STAT3—breast cancer	4.05e-06	6.69e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MAPK3—breast cancer	3.87e-06	6.39e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PTEN—breast cancer	3.79e-06	6.26e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—MYC—breast cancer	3.76e-06	6.21e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—TGFB1—breast cancer	3.75e-06	6.2e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—EGFR—breast cancer	3.68e-06	6.08e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—KRAS—breast cancer	3.48e-06	5.74e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—PIK3CA—breast cancer	3.19e-06	5.27e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—HRAS—breast cancer	2.96e-06	4.88e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—IL6—breast cancer	2.83e-06	4.67e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—PIK3CA—breast cancer	2.68e-06	4.42e-05	CbGpPWpGaD
Zoledronate—ABCC1—Disease—AKT1—breast cancer	2.61e-06	4.31e-05	CbGpPWpGaD
Zoledronate—ABCC1—Metabolism—AKT1—breast cancer	2.19e-06	3.61e-05	CbGpPWpGaD
